Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials
Triple-negative breast cancer (TNBC) is an aggressive subtype with no hormone or HER2 targets. Learn the latest treatment strategies-including immunotherapy, PARP inhibitors, antibody-drug conjugates, and personalized vaccines-plus key clinical trials changing outcomes in 2025.
